N-biaryl and N-arylheteroaryl piperazine derivatives as modulators of the 5HT2C receptor useful for the treatment of disorders related thereto

Details for Australian Patent Application No. 2005316825 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Estrada, Scott A.; Ibarra, Jason B.; Santora, Vincent J.; Smith, Brian M.; Schultz, Jeffrey A.; Hayashi, Rena

Agent FB Rice

Pub. Number AU-A-2005316825

PCT Pub. Number WO2006/065600

Priority 60/635,785 13.12.04 US

Filing date 9 December 2005

Wipo publication date 22 June 2006

International Classifications

C07D 295/06 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 295/08 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/52 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/065600 Priority application(s): WO2006/065600

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316826-Inhibitors of Akt activity

2005316824-Method of using extracts of epimedium species